Literature DB >> 28095978

Poor Quality Control of Over-the-Counter Melatonin: What They Say Is Often Not What You Get.

Madeleine M Grigg-Damberger1,2, Dessislava Ianakieva3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28095978      PMCID： PMC5263069          DOI： 10.5664/jcsm.6434

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN： 1550-9389            Impact factor:   4.062


× No keyword cloud information.
  22 in total

1.  The absolute bioavailability of oral melatonin.

Authors:  R L DeMuro; A N Nafziger; D E Blask; A M Menhinick; J S Bertino
Journal:  J Clin Pharmacol       Date:  2000-07       Impact factor: 3.126

Review 2.  Potential safety issues in the use of the hormone melatonin in paediatrics.

Authors:  David J Kennaway
Journal:  J Paediatr Child Health       Date:  2015-02-03       Impact factor: 1.954

Review 3.  Melatonin therapy for REM sleep behavior disorder: a critical review of evidence.

Authors:  Ian R McGrane; Jonathan G Leung; Erik K St Louis; Bradley F Boeve
Journal:  Sleep Med       Date:  2014-10-13       Impact factor: 3.492

Review 4.  Emerging Role of Melatonin and Melatonin Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients.

Authors:  Yoonsun Mo; Corey E Scheer; George T Abdallah
Journal:  J Intensive Care Med       Date:  2015-06-19       Impact factor: 3.510

5.  Effects of exogenous melatonin on sleep: a meta-analysis.

Authors:  Amnon Brzezinski; Mark G Vangel; Richard J Wurtman; Gillian Norrie; Irina Zhdanova; Abraham Ben-Shushan; Ian Ford
Journal:  Sleep Med Rev       Date:  2005-02       Impact factor: 11.609

6.  Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials.

Authors:  Wei Zhang; Xue-Yan Chen; Su-Wen Su; Qing-Zhong Jia; Tao Ding; Zhong-Ning Zhu; Tong Zhang
Journal:  Neurol Sci       Date:  2015-08-09       Impact factor: 3.307

Review 7.  Melatonin as an antioxidant: under promises but over delivers.

Authors:  Russel J Reiter; Juan C Mayo; Dun-Xian Tan; Rosa M Sainz; Moises Alatorre-Jimenez; Lilian Qin
Journal:  J Pineal Res       Date:  2016-09-01       Impact factor: 13.007

8.  Increased Melatonin Signaling Is a Risk Factor for Type 2 Diabetes.

Authors:  Tiinamaija Tuomi; Cecilia L F Nagorny; Pratibha Singh; Hedvig Bennet; Qian Yu; Ida Alenkvist; Bo Isomaa; Bjarne Östman; Johan Söderström; Anu-Katriina Pesonen; Silja Martikainen; Katri Räikkönen; Tom Forsén; Liisa Hakaste; Peter Almgren; Petter Storm; Olof Asplund; Liliya Shcherbina; Malin Fex; João Fadista; Anders Tengholm; Nils Wierup; Leif Groop; Hindrik Mulder
Journal:  Cell Metab       Date:  2016-05-12       Impact factor: 27.287

9.  Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study.

Authors:  Doron Garfinkel; Mariana Zorin; Julio Wainstein; Zipora Matas; Moshe Laudon; Nava Zisapel
Journal:  Diabetes Metab Syndr Obes       Date:  2011-08-02       Impact factor: 3.168

10.  The Efficacy of Oral Melatonin in Improving Sleep in Cancer Patients with Insomnia: A Randomized Double-Blind Placebo-Controlled Study.

Authors:  Madhuri S Kurdi; Sindhu Priya Muthukalai
Journal:  Indian J Palliat Care       Date:  2016 Jul-Sep
View more
  6 in total

Review 1.  Adverse Events Associated with Melatonin for the Treatment of Primary or Secondary Sleep Disorders: A Systematic Review.

Authors:  Frank M C Besag; Michael J Vasey; Kim S J Lao; Ian C K Wong
Journal:  CNS Drugs       Date:  2019-12       Impact factor: 5.749

Review 2.  Melatonin's Benefits and Risks as a Therapy for Sleep Disturbances in the Elderly: Current Insights.

Authors:  Daniel P Cardinali; Gregory M Brown; Seithikurippu R Pandi-Perumal
Journal:  Nat Sci Sleep       Date:  2022-10-14

Review 3.  Efficacy and safety of supplemental melatonin for delayed sleep-wake phase disorder in children: an overview.

Authors:  David Mantle; Marcel Smits; Myrthe Boss; Irene Miedema; Inge van Geijlswijk
Journal:  Sleep Med X       Date:  2020-08-19

Review 4.  Benefits and adverse events of melatonin use in the elderly (Review).

Authors:  Lucreția Anghel; Liliana Baroiu; Corina Rișcă Popazu; Diana Pătraș; Silvia Fotea; Alexandru Nechifor; Anamaria Ciubara; Luiza Nechita; Carmina Liana Mușat; Ioana Anca Stefanopol; Alin Laurențiu Tatu; Alexandru Bogdan Ciubara
Journal:  Exp Ther Med       Date:  2022-01-14       Impact factor: 2.447

Review 5.  Use of Melatonin and/on Ramelteon for the Treatment of Insomnia in Older Adults: A Systematic Review and Meta-Analysis.

Authors:  Srujitha Marupuru; Daniel Arku; Ashley M Campbell; Marion K Slack; Jeannie K Lee
Journal:  J Clin Med       Date:  2022-08-31       Impact factor: 4.964

6.  Melatonin Increases Life Span, Restores the Locomotor Activity, and Reduces Lipid Peroxidation (LPO) in Transgenic Knockdown Parkin Drosophila melanogaster Exposed to Paraquat or Paraquat/Iron.

Authors:  Hector Flavio Ortega-Arellano; Marlene Jimenez-Del-Rio; Carlos Velez-Pardo
Journal:  Neurotox Res       Date:  2021-08-02       Impact factor: 3.911
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.